Trial Profile
A phase II trial of a prostaglandin D2 receptor antagonist for the treatment of asthma.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2012
Price :
$35
*
At a glance
- Drugs Prostaglandin D2 receptor antagonists (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 01 Aug 2012 New trial record